[{"NetIncomeLoss_2_Q2_USD":170800000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":52400000.0,"DefinedBenefitPlanExpectedReturnOnPlanAssets_1_Q2_USD":2500000.0,"DefinedBenefitPlanExpectedReturnOnPlanAssets_2_Q2_USD":4900000.0,"InventoryRawMaterialsAndSupplies_0_Q2_USD":338500000.0,"ConstructionInProgressGross_0_Q2_USD":558500000.0,"PaymentsToAcquireInvestments_2_Q2_USD":1000000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":81800000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-354400000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-329600000.0,"InterestPaidNet_2_Q2_USD":52000000.0,"AssetsCurrent_0_Q2_USD":2518900000.0,"PreferredStockValueOutstanding_0_Q2_USD":0.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":3200000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q2_USD":39900000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2_Q2_USD":55700000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":54800000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":91700000.0,"DepreciationAndAmortization_1_Q2_USD":71000000.0,"DepreciationAndAmortization_2_Q2_USD":140100000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q2_USD":-9400000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_Q2_USD":-16000000.0,"InventoryGross_0_Q2_USD":495500000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":122900000.0,"RestructuringSettlementAndImpairmentProvisions_2_Q2_USD":6400000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q2_USD":5500000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2_Q2_USD":-1000000.0,"DefinedBenefitPlanInterestCost_2_Q2_USD":2100000.0,"DividendsAndInterestPaid_2_Q2_USD":13000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":40400000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":56700000.0,"Assets_0_Q2_USD":8198100000.0,"ProceedsFromRepurchaseOfEquity_2_Q2_USD":81800000.0,"CommonStockSharesIssued_0_Q2_shares":170133258.0,"IncomeTaxesPaidNet_2_Q2_USD":18900000.0,"FurnitureAndFixturesGross_0_Q2_USD":22400000.0,"ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_2_Q2_USD":25400000.0,"ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_1_Q2_USD":11800000.0,"InventoryValuationReserves_0_Q2_USD":34200000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":0.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":359000000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":612600000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":1209400000.0,"ContractWithCustomerLiability_0_Q2_USD":273100000.0,"DerivativeGainLossOnDerivativeNet_1_Q2_USD":7000000.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":16000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":165500000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":330200000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q2_USD":-500000.0,"EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_0_Q2_USD":4100000.0,"PreferredStockSharesOutstanding_0_Q2_shares":384777.0,"DeferredIncomeTaxLiabilities_0_Q2_USD":66500000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":68800000.0,"DefinedBenefitPlanNetPeriodicBenefitCost_1_Q2_USD":400000.0,"DefinedBenefitPlanNetPeriodicBenefitCost_2_Q2_USD":600000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":253000000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_Q2_USD":253000000.0,"Revenues_2_Q2_USD":1756500000.0,"Revenues_1_Q2_USD":910800000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":17800000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":20600000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":5600000.0,"AccountsReceivableNetCurrent_0_Q2_USD":771500000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":8100000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":18700000.0,"PrepaidExpenseCurrent_0_Q2_USD":47500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":169279089.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":88400000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":170800000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":92500000.0,"EarningsPerShareBasic_2_Q2_USD":0.88,"EarningsPerShareBasic_1_Q2_USD":0.46,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":621200000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":5200000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":11600000.0,"ValueAddedTaxReceivable_0_Q2_USD":33400000.0,"InterestPayableCurrent_0_Q2_USD":30000000.0,"DefinedBenefitPlanInterestCost_1_Q2_USD":1100000.0,"DebtAndCapitalLeaseObligations_0_Q2_USD":3055800000.0,"OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_1_Q2_USD":700000.0,"PrepaidTaxes_0_Q2_USD":21500000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":15300000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":200000.0,"Liabilities_0_Q2_USD":4383600000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":4160800000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":833100000.0,"OtherAssetsNoncurrent_0_Q2_USD":188000000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":23000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":46000000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":13400000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":76600000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":145400000.0,"GoodwillOtherIncreaseDecrease_2_Q2_USD":-1300000.0,"MachineryAndEquipmentGross_0_Q2_USD":1292100000.0,"IncreaseDecreaseInInventories_2_Q2_USD":140300000.0,"OtherAssetsCurrent_0_Q2_USD":27700000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-7200000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q2_USD":200000.0,"ForeignCurrencyTransactionGainLossUnrealized_2_Q2_USD":800000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":12000000.0,"DepreciationExpenseOnReclassifiedAssets_1_Q2_USD":48000000.0,"DepreciationExpenseOnReclassifiedAssets_2_Q2_USD":94100000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":140100000.0,"OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_2_Q2_USD":1400000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"DeferredIncomeTaxAssetsNet_0_Q2_USD":44600000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"AccountsPayableCurrent_0_Q2_USD":356900000.0,"DeferredRevenueCurrent_0_Q2_USD":260600000.0,"LiabilitiesCurrent_0_Q2_USD":1024000000.0,"InventoryWorkInProcess_0_Q2_USD":157000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":167075141.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":165589730.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":223700000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":39400000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":55300000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":11400000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":30100000.0,"TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_1_Q2_USD":-45400000.0,"TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_2_Q2_USD":-77800000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":6800000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":26400000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":300000.0,"InterestIncomeExpenseNet_1_Q2_USD":-25900000.0,"InterestIncomeExpenseNet_2_Q2_USD":-51200000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q2_USD":2983800000.0,"Goodwill_0_Q2_USD":2461500000.0,"TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax_1_Q2_USD":58900000.0,"TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax_2_Q2_USD":94300000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1084500000.0,"NonoperatingIncomeExpense_2_Q2_USD":19500000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":90600000.0,"NonoperatingIncomeExpense_1_Q2_USD":8300000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":595100000.0,"NetIncomeLoss_1_Q2_USD":88400000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2129800000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":3700000.0,"TemporaryEquityIssuePeriodIncreaseOrDecrease_2_Q2_USD":-247600000.0,"TemporaryEquityIssuePeriodIncreaseOrDecrease_1_Q2_USD":-247600000.0,"PreferredStockSharesIssued_0_Q2_shares":384777.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_1_Q2_USD":-600000.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_2_Q2_USD":-2400000.0,"InterestRateCashFlowHedgeLiabilityAtFairValue_0_Q2_USD":3700000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":855300000.0,"OtherNonrecurringIncome_1_Q2_USD":8300000.0,"OtherNonrecurringIncome_2_Q2_USD":19500000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":3455500000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":-5300000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":2203948.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":2498460.0,"AccumulatedCapitalizedInterestCosts_0_Q2_USD":4000000.0,"GrossProfit_1_Q2_USD":298200000.0,"GrossProfit_2_Q2_USD":547100000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":855300000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":200000.0,"DefinedBenefitPlanAmortizationOfGainsLosses_1_Q2_USD":-800000.0,"DefinedBenefitPlanAmortizationOfGainsLosses_2_Q2_USD":-1400000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":453000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":128800000.0,"AmortizationOfFinancingCosts_2_Q2_USD":3300000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":89600000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":3214300000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":11400000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":30100000.0,"PreferredStockSharesAuthorized_0_Q2_shares":100000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":151900000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":8198100000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1_Q2_USD":200000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_2_Q2_USD":400000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":1476500000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q2_USD":-500000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2_Q2_USD":-1000000.0,"InventoryNet_0_Q2_USD":461300000.0,"ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_1_Q2_USD":30000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_2_Q2_USD":39300000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":109000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":176400000.0,"OperatingIncomeLoss_1_Q2_USD":126600000.0,"OperatingIncomeLoss_2_Q2_USD":208100000.0,"CommonStockValueOutstanding_0_Q2_USD":1700000.0,"CommonStockSharesAuthorized_0_Q2_shares":1000000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":14800000.0,"DefinedBenefitPensionPlanLiabilitiesNoncurrent_0_Q2_USD":141900000.0,"DefinedBenefitPlanServiceCost_2_Q2_USD":2000000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":49400000.0,"DefinedBenefitPlanServiceCost_1_Q2_USD":1000000.0,"ProfitLoss_2_Q2_USD":170800000.0,"EarningsPerShareDiluted_1_Q2_USD":0.45,"EarningsPerShareDiluted_2_Q2_USD":0.87,"CommonStockSharesOutstanding_0_Q2_shares":170133258.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1_Q2_USD":-700000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_2_Q2_USD":-1400000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-87600000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-120100000.0,"DividendsPreferredStock_1_Q2_USD":4900000.0,"DividendsPreferredStock_2_Q2_USD":13000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-377400000.0,"DebtCurrent_0_Q2_USD":72000000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_1_Q2_USD":1900000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_2_Q2_USD":3700000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":82100000.0,"ProceedsFromRepaymentsOfShortTermDebt_2_Q2_USD":1500000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":338900000.0,"DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_1_Q2_USD":-2500000.0,"DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_2_Q2_USD":-4400000.0,"StockholdersEquity_0_Q2_USD":3455500000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":5400000.0,"OtherLiabilitiesCurrent_0_Q2_USD":126000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":167400000.0,"ProfitLoss_1_Q2_USD":88400000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":46600000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":227500000.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20210202"}]